ANTI-CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR TESTING PATTERNS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN THE US

被引：1
|
作者：
An, J. [1 ]
Lin, A. [2 ]
Bider, Z. [3 ]
Alemao, E. [4 ]
Connolly, S. E. [4 ]
Cheetham, T. C. [3 ]
机构：
[1] Western Univ Hlth Sci, Pomona, CA USA
[2] Southern Calif Permanente Med Grp, Fontana, CA USA
[3] Southern Calif Permanente Med Grp, Pasadena, CA USA
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1431
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1006
引用
收藏
页码：1245 / 1246
页数：2
相关论文
共 50 条
  • [21] Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis
    Trier, Nicole Hartwig
    Houen, Gunnar
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023,
  • [22] Systematic Review: Accuracy of Anti-Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
    Whiting, Penny F.
    Smidt, Nynke
    Sterne, Jonathan A. C.
    Harbord, Roger
    Burton, Anya
    Burke, Margaret
    Beynon, Rebecca
    Ben-Shlomo, Yoav
    Axford, John
    Dieppe, Paul
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (07) : 456 - W166
  • [23] ACPA [ANTI-CITRULLINATED PROTEIN ANTIBODIES) AND RHEUMATOID ARTHRITIS
    Toes, Rene E. M.
    van der Woude, Diane
    ACTA REUMATOLOGICA PORTUGUESA, 2011, 36 (03): : 205 - 207
  • [24] Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis
    Geraldino-Pardilla, Laura
    Giles, Jon T.
    Sokolove, Jeremy
    Zartoshti, Afshin
    Robinson, William H.
    Budoff, Matthew
    Detrano, Robert
    Bokhari, Sabahat
    Bathon, Joan M.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (08) : 1276 - 1281
  • [25] Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis
    Wanruchada Katchamart
    Ajchara Koolvisoot
    Emvalee Aromdee
    Praveena Chiowchanwesawakit
    Chayawee Muengchan
    Rheumatology International, 2015, 35 : 1693 - 1699
  • [26] Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis
    Katchamart, Wanruchada
    Koolvisoot, Ajchara
    Aromdee, Emvalee
    Chiowchanwesawakit, Praveena
    Muengchan, Chayawee
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (10) : 1693 - 1699
  • [27] Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis
    Arleevskaya, Marina, I
    Boulygina, Eugenia A.
    Larionova, Regina
    Validov, Shamil
    Kravtsova, Olga
    Shagimardanova, Elena, I
    Velo, Lourdes
    Hery-Arnaud, Genevieve
    Carle, Caroline
    Renaudineau, Yves
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [28] Anti-citrullinated peptide antibody: death of the rheumatoid factor?
    Chatfield, Simon M.
    Wicks, Ian P.
    Sturgess, Allan D.
    Roberts, Lynden J.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (12) : 693 - 695
  • [29] Predictive Utility of Anti-Citrullinated Peptide Antibodies and Rheumatoid Factor - a Retrospective Dataanalysis
    Gaertner, Miriam
    Schneeweiss, Mathias
    Smolen, Josef S.
    Machold, Klaus
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Chen, HA
    Lin, KC
    Chen, CH
    Liao, HT
    Wang, HP
    Chang, HN
    Tsai, CY
    Chou, CT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
12345